- Research article
- Open Access
Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: An exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya
BMC Evolutionary Biology volume 8, Article number: 173 (2008)
Minor alleles of the human dopamine receptor polymorphisms, DRD2/TaqI A and DRD4/48 bp, are related to decreased functioning and/or numbers of their respective receptors and have been shown to be correlated with body mass, height and food craving. In addition, the 7R minor allele of the DRD4 gene is at a higher frequency in nomadic compared to sedentary populations. Here we examine polymorphisms in the DRD2 and DRD4 genes with respect to body mass index (BMI) and height among men in two populations of Ariaal pastoralists, one recently settled (n = 87) and the other still nomadic (n = 65). The Ariaal live in northern Kenya, are chronically undernourished and are divided socially among age-sets.
Frequencies of the DRD4/7R and DRD2/A1 alleles were 19.4% and 28.2%, respectively and did not differ between the nomadic and settled populations. BMI was higher in those with one or two DRD4/7R alleles in the nomadic population, but lower among the settled. Post-hoc analysis suggests that the DRD4 differences in BMI were due primarily to differences in fat free body mass. Height was unrelated to either DRD2/TaqI A or DRD4/48 bp genotypes.
Our results indicate that the DRD4/7R allele may be more advantageous among nomadic than settled Ariaal men. This result suggests that a selective advantage mediated through behaviour may be responsible for the higher frequency of the 7R alleles in nomadic relative to sedentary populations around the world. In contrast to previous work, we did not find an association between DRD2 genotypes and height. Our results support the idea that human phenotypic expression of genotypes should be rigorously evaluated in diverse environments and genetic backgrounds.
Genetic variations in the dopamine (DA) system have been related to nutritional indices [1–11] and a nomadic lifestyle . While human neurological, behavioural and physiological genetics is a vast field, little such research has been conducted among people living in non-industrialized or subsistence environments. Such environments may be more similar to the environments where much of human genetic evolution took place; indeed, they may be adaptively relevant environments [AREs; ] for the evolution of dopamine gene polymorphisms that have been primarily investigated in industrialized settings. Here we examine the relationships between genetic polymorphisms of dopamine receptor genes and several phenotypes in Ariaal men.
The Ariaal are traditionally nomadic pastoralists living in northern Kenya. They are mainly a subsistence population with low percent body-fat and chronic under-nutrition . Roughly half of our sample consists of nomads, while the other half are from a group that has been settled for about 35 years and practices some agriculture [15, 16]. This contrast between nomadic and settled Ariaal groups provides an opportunity to test for gene by environment interactions across two environments inhabited by genetically and culturally similar peoples. We examine how two dopamine receptor genetic polymorphisms relate to measures of nutrition/body composition among these two groups. To the best of our knowledge, this is the first study to examine correlates of dopamine genetic variation in a subsistence society.
Dopamine gene polymorphisms and their correlates
This study analyzes the correlates of two genetic polymorphisms, the TaqI A polymorphism in the dopamine receptor D2 (DRD2) gene and the 48 base pair (bp) repeat polymorphism in the dopamine receptor D4 (DRD4) gene. There is evidence that minor alleles of both DRD2 and DRD4 (A1 and 7R respectively) decrease the sensitivity and/or concentrations of their respective receptors [17–24]. Thus, minor alleles can be viewed as analogous to their respective dopamine receptor antagonists (although this neglects developmental effects), and thus provide natural experiments to dissect aspects of human physiology. DRD2 and DRD4 are both considered D2-like receptors and have similar functions and distributions, but are distinct. DRD2 seems to be particularly important in the striatum, whereas DRD4 appears more important in the prefrontal cortex [reviewed in ]. Both are likely involved in impulsivity, reward anticipation and addiction and they may interact in a complex manner to effect phenotypes [reviewed in [25, 26]].
The DRD4/48 bp polymorphism has been associated with body mass index [BMI = weight in kg/height in meters^2; [9–11], however ] and food craving . The allele frequencies of DRD4/48 bp vary considerable across populations and the 7R minor allele is generally at a higher frequency in populations that have migrated farther or are nomadic rather than sedentary  and among individuals with multi-racial ancestries . It appears that the 7R allele emerged and began being positively selected for about 45,000 years ago .
The A1 allele of the DRD2/TaqI A polymorphism has often been associated with substance abuse . The DRD2 gene has also been variously related to BMI and related indices of metabolic syndrome [1–8, 31]. Lower striatal D2 receptor availability has been related to obesity and increased BMI . Those with DRD2 A1 alleles have higher food reinforcement (are willing to work harder for food) and consume more food than their counterparts without A1 alleles [33, 34], suggesting DRD2 impacts nutritional status through food craving behaviour.
Increases in height have been reported among children who were exposed pre- or post-natally to D2 receptor blocking drugs [reviewed in ]. Additionally, among four independent sets of subjects DRD2 polymorphisms were related to height [35–37].
Predictions and findings
Based on past research suggesting that BMI associations with dopamine receptor polymorphisms are due to increased food craving [36, 38], we expected that BMI would be related to dopamine receptor genotype. However, food craving in western environments of plenty might have very different implications than among undernourished Ariaal men. Based on observations that nomads around the world have higher DRD4/7R allele frequencies relative to settled populations , we predicted that 7R+ nomads would have better relative indices of nutrition than 7R+ settled Ariaal.
We compared allele frequencies between the settled and nomadic men, but due to the settled group's recent formation  and continued gene flow with the nomads, we did not have clear expectations for allele frequency differences.
We also expected that DRD2 would be associated with height as shown in previous research. Since height is a key variable in calculating BMI and DRD2 and DRD4 are functionally related, height was examined in relation to both DRD2 and DRD4.
We found that BMI was higher in individuals with one or two 7R alleles in the nomadic population, but was lower in settled individuals with the 7R allele. Post-hoc analysis suggests that these DRD4-related differences in BMI were mainly due to differences in fat free mass. Height was unrelated to dopamine genetic polymorphisms.
Results and Discussion
Allele and genotype frequencies in nomadic and settled men
DRD4 allele and genotype frequencies are shown in Table 1. Settled and nomadic Ariaal did not differ in their 7R allele frequencies (Pearson chi-square = 0.26, df = 1, p = 0.610) nor were there significant differences in overall allele frequencies (Fisher's exact test, p = 0.906). The DRD4 genotype frequencies of the settled and nomadic Ariaal pooled together were in Hardy-Weinberg equilibrium (HWE; Markov Chain algorithm, p = 0.124) as well as in the nomads alone (p = 0.735). The DRD4 genotype frequency among settled Ariaal was slightly out of HWE (Markov Chain algorithm, p = 0.036), but when the single 5R/5R individual was excluded from the analysis, HWE was maintained (p = 0.425). No 2R alleles, the third most common and likely functionally distinct allele, were found in either the nomadic or sedentary samples; consistent with a lack of 2R alleles in some other African populations . DRD2 allele and genotype frequencies are shown in Table 2. The DRD2 genotype frequencies of the settled and nomadic Ariaal pooled together was in HWE (Fisher's exact test, p = 0.554) as well as for the settled (Fisher's Exact, p = 0.135) and nomadic groups separately (Fisher's Exact, p = .526).
Body Composition/Nutritional Status
Descriptions of the anthropometric variables used in this study, including BMI and height, are given in Table 3 for the pooled population and two sub-populations. The nomadic and settled groups of men that make up the sample are on average underweight, having BMIs below the 18.5 standard of normal-weight [40, 41]. General Linear Models to evaluate the relation of DRD2 and DRD4 with anthropometrics first included DRD2, DRD4, residence and all two-way interactions and then, in a separate model, included variables shown in past studies to be associated with the anthropometric measure of interest [14, 42, 43]. As can be seen in Models 1 & 2 of Table 4, a strong interaction between DRD4 and residence with BMI was evident. The nature of this interaction between DRD4 and residence is illustrated in Figure 1, where among nomads 7R+ was related to being less underweight (higher BMI), but among settled men, 7R+ individuals were more underweight (lower BMI).
Height did not show the predicted association with DRD2, nor was height associated with DRD4 (Table 4; Models 3 and 4). Closer examination of the only other study specifically testing for an association between DRD2/TaqI A and height suggests that the A1 allele may differ in its linkages in different populations. In that study, idiopathic short stature was associated with A1 alleles in Japanese subjects . Increases in height have been reported among children who were exposed pre or post-natally to D2 receptor blocking drugs [reviewed in ]. However, the A1 allele of the DRD2/TaqIA polymorphism is generally associated with decreased DRD2 functioning/expression [reviewed in ], so together with the D2 receptor blocking studies, we should expect A1 alleles to be associated with increased (not decreased) height. Since the A1 allele is not thought to be a functional polymorphism in the dopamine system (elaborated in the methods section), varying genetic background (i.e. different patterns of linkage with actual functional genetic polymorphisms) could explain varying results across populations.
Since BMI is a coarse measure of body composition we conducted further post-hoc analysis in an effort to understand the associations of DRD4 with body composition at a finer level. We analyzed upper arm muscle area plus bone area (AMPBA) because it represents short term energy balance/storage  and low values of AMPBA in the elderly are associated with increased mortality , triceps skinfold (TSK) as a measure of energy stores and current energy balance , percent body fat (%BF) as a measure of general adiposity, fat free mass (FFM) as another measure of body size, and suprailliac skinfold (SSK) as a measure of abdominal fat, thought to be the most metabolically active fat depot .
AMPBA might be associated with DRD4 and DRD2 through interactions with residence, although the effect significance depends on the other covariates in the models (Table 4, Models 5 and 6). Nomads with 7R alleles had higher AMPBA, whereas little or no difference was found in settled individuals (Figure 2). Based on an expectation of similar effects of DRD2 and DRD4 minor alleles, it is peculiar that the DRD2 A1+ genotype was near significantly associated with decreased AMPBA among the nomads (Figure 3). Perhaps this can be understood as effects of DRD2 on GH and IGF-1 mediated muscle formation [37, 47] or maintenance [48, 49]. However, such an explanation of DRD2's effect on AMPBA is not consistent with our suggested explanation for the lack of association of DRD2 with height.
In models 7–9, 12 & 13 (Table 4), we show that TSK, %BF and SSK were not related to DRD2 or DRD4 genotypes. However, models 10 & 11 (Table 4), show a relatively strong association between the interaction of DRD4 and residence with fat free mass (FFM). Inclusion of additional relevant covariates increases the significance of this interaction and the explanatory power of the model (adjusted r2). The direction of the association with FFM (Figure 4) was the same as with BMI (Figure 1); nomads with 7R alleles had higher FFM than their nomadic counterparts without 7R alleles, and the effect of DRD4 was reversed and of a lesser magnitude among the settled. Since FFM has previously been shown to vary with age group [Table 4, Model 11; ], we additionally checked for DRD4 by age group and DRD4 by residence by age group interactions, but these were not evident (not shown).
Table 5 is provided to explore the inheritance patterns (e.g. recessive, dominant, additive or other) of the associations of DRD4 with BMI and FFM. The association of DRD4 with BMI seems to exhibit an additive relationship; as the number of 7R alleles increases from zero 7R alleles (7R-/7R-), to one 7R allele (7R/7R-), to two (7R/7R), BMI decreases in the settled men, but increases in the nomads. FFM, which was more closely related to DRD4, does not exhibit as clear a trend. This analysis is obviously limited by the low sample sizes, especially among 7R homozygotes.
DRD4 7R+ seems to increase total non-fat mass (FFM) of the body, but only among nomads. FFM is defined as bodyweight minus body-fat weight and thus primarily measures the sum of the masses of muscle, bone, and organs. With this exclusion of fat mass, FFM represents the more metabolically active body portions . FFM is a general index of body-size and in a chronically underweight population, can reasonably be assumed to represent greater body-size and/or greater muscular and bone mass. However, given the lack of association of DRD4 with height, the latter suggestion of increased muscle and bone mass seems more likely. In an undernourished population with low % body fat (Table 3), increased muscle and bone mass might actually represent less starvation induced breakdown of muscle mass and higher nutrient stores (perhaps due to nutritional protein deficiency) .
The finding that the 7R allele had a positive association with BMI, FFM and AMPBA among nomads, but a negative one among settled individuals is consistent with past findings of higher 7R allele frequencies in nomadic populations around the world . While dopaminergic pathways clearly are involved in food craving (see above), the significance of increased food cravings is unclear in a nutrient poor environment, where food to satisfy such cravings is not readily available. That 7R alleles are associated with selfishness  might also mean that while craving food more those 7R men are also less likely to share food. However, it is unclear why food craving or selfishness should vary in its outcome by residence among the Ariaal.
HIV infection, common in Kenya, can cause wasting. Past study among the Ariaal suggest low rates of condom usage and a cultural acceptability for men to have multiple simultaneous sexual partners . Sexual behaviours have been related to DRD4 [29, 54, 55] which might alter sexually-transmitted disease risks. However, information on HIV infection rates among the Ariaal is not available.
Increased impulsivity, ADHD-like traits, novelty-seeking like traits [reviewed in ], aggression [56, 57], violence  and/or activity levels [58, 59] may help nomads obtain food resources, or exhibit a degree of behavioural unpredictability  that is protective against interpersonal violence or robberies [61, 62]. Increased activity levels, if not resulting in increased food access, likely would decrease nutritional stores. The 7R allele might also promote better infant survival [63–66] depending upon the social and ecological context. Alternatively, these associations may represent some other more basic metabolic influence of DRD4, such as regulation of physical activity in high temperature environments [67–69]. Regardless of the mechanism, the fact that the DRD4 7R allele remains at relatively low frequency (less than 20%) despite indications that it contributes to improved somatic condition among nomads, suggests that the 4R/7R polymorphism is maintained by frequency dependent selection [62, 70] (or perhaps, but less likely heterozygote advantage ).
We recognize that both DRD2 and DRD4 genotypes are sometimes parsed differently than shown here. To allow further analysis and comparisons with other studies, we have included the complete dataset used for this manuscript as Additional files 1 &2. As well, full statistics, effect sizes and observed power for models 2 and 11 from Table 4 are given in Additional files 3 and 4 respectively.
The DRD2 gene was not associated with height in this non-industrialized group – at variance with four previous studies. We note that the TaqI A polymorphism is itself not know to be functional (see methods), so this finding could be due to differences in genetic linkage by population. Re-sequencing or more extensive haplotype analysis of this region in this and other populations might elucidate the matter. Alternatively, population specific epistatic interactions or the chronic undernutrition experienced by the Ariaal men in this sample might alter the relative expression/importance of DRD2 genotypes in determining height.
We found that DRD4 7R+ genotypes were associated with indices of better nutritional status among nomads, particularly higher fat free mass, but worse indices in the settled individuals. This suggests that the 7R allele confers additional adaptive benefits in the nomadic compared to sedentary context. These benefits might be derived from behavioural or metabolic differences between genotypes that vary either in their physiological/psychological phenotypic expression or practical result by context. Future study will be required to distinguish between potential mechanisms involved.
In order to elucidate the current finding, future studies among the Ariaal might look more specifically at food intake, attention in children, mechanisms of defence of livestock and/or activity levels. It might be that the attention spans conferred by the DRD4/7R+ genotype allow nomadic children to more readily learn effectively in a dynamic environment (without schools), while the same attention span interferes with classroom learning in Songa, the settled community. 7R+ boys might develop into warriors (the life-stage of an Ariaal male that lies between childhood and manhood) and men who can more effectively defend against livestock raiders, perhaps through a reputation of unpredictable behaviour that inspires fear. Among 7R+ men in the settled community of Songa, such tendencies might be less well suited to practicing agriculture and selling goods at market. It might also be that higher activity levels in 7R+ nomads are translated into increased food production, while such activity levels in settled men are a less efficient use of calories in food production.
This study highlights the importance of studying human biology, and genetic polymorphisms in particular, in diverse environments and among genetically distinct populations.
Populations and Field Work
The Ariaal are pastoralists inhabiting both upland and lowland regions in the Marsabit district of Kenya. First appearing in oral history in the 1880s, they are derived from a group of poor Rendille and Samburu groups who banded together to build up their herds in the mountains. Culturally, they still exhibit features of both Rendille and Samburu, including Samburu age-set rituals and Rendille annual camel blessings . Ariaal derive their subsistence from herding camels, cattle, goats, and sheep, which they depend on for nutrition in the form of milk, blood, and meat.
In August of 2005, as part of a study on male aging, Ariaal participants were recruited from two venues: 103 men from the settled agropastoral community of Songa and 102 nomadic males from the nomadic settlement of Lewogoso on the Kasuit Plateau. Potential subjects were identified by a scattershot method (no selection criteria) in the settled and nomadic community, and the final sample stratified by ten year age groups; 20–29, 30–39, 40–49, 50–59, 60+.
In Songa, maize and other foodstuffs make important contributions to the diet . The existence of drip-irrigation supports the production of crops including oranges that are sold in the nearby town of Marsabit, approximately 45 minutes away. Songa also includes an elementary school and a nurse's station. In the nomadic community, Lewogoso, all eligible men were asked to participate. Lewogoso is located approximately 45 minutes from the Settlement of Korr and 3 hours from the town of Marsabit by vehicle. The nearest clinic is in Ngrunit about 40 minutes away. Children do not attend elementary school.
Interviews, assisted by trained translators in the appropriate language (Samburu and/or Rendille), were conducted with each participant. Interviews focused on demographic background, marital and reproductive history, social support and age-related quality of life outcomes. During interviews, ages were estimated with reference to an event calendar and age set membership, and further ambiguities checked with local assistants [for further details see ].
Anthropometrics, genetic and hormone measures
Anthropometric measures included height, weight, arm, waist and hip circumference and five skinfolds: triceps, subscapular, midaxillary, suprailliac and periumbilical. All anthropometric measures were taken by an experienced human biologist (BC). Derived measures include % body fat, calculated from skinfolds based on the D-W equations . Because the D-W equations are based on a Caucasian sample, they may provide absolute values of % body fat that are not directly comparable with other populations. However, they should provide a relatively consistent measure of % body fat within the study population considered here. We also derived arm muscle plus bone area (AMPBA), calculated as ([MUAC - (π × TCSF/10)]2)/4 where MUAC is mid upper arm circumference in cm and TCSF is the triceps skinfold in mm . Fat free mass (FFM) was calculated as weight * ([100 - % body fat]/100).
Hair samples with roots were obtained by plucking, and immediately placed in zip lock bags for transportation to the lab of MDS. We obtained hair samples from 156 men, including 87 settled and 69 nomadic men. The other men lacked sufficient hair to obtain a sample, either because of baldness or the fact that they had shaved their heads. Samples were stored at ambient temperature in the field and then in a -20°C freezer until analysis. Bulbs were removed from hairs under a dissecting microscope, and DNA was extracted with a DNeasy Tissue Kit (Qiagen) and eluted in 200 μl of tris elution buffer.
DRD4 48 bp VNTR
The DRD4 48-bp VNTR polymorphism is in exon 3 of the gene coding for the dopamine D4 receptor. The VNTR polymorphism varies between 2 and 11 repeats of a similar 48 bp coding region sequence, with a tri-modal distribution of 2, 4 and 7 repeat alleles (2R, 4R and 7R) in most, but not all, populations . While the functional significance of the DRD4 VNTR polymorphism has not been definitively characterized, long alleles (typically 7R as opposed to 4R) might be functionally less reactive based on in-vitro expression experiments [20–24], however much heterogeneity still exists [76–80]. Similarly, in vivo human pharmacological studies are generally consistent with the notion that 7R alleles are associated with less responsive D4 receptors than 4R alleles [81–85].
The DRD4 48 bp VNTR locus was genotyped using an adaptation of a previous protocol [25, 86]. The PCR reaction contained 1× Q-Solution (Qiagen), 1× PCR Buffer (Qiagen), 1 μM Primer F1 (5' GCGACTACGTGGTCTACTCG 3'), 1 μM Primer R1 (5' AGGACCCTCATGGCCTTG 3'), 200 μM dATP, dTTP, dCTP and 100 μM dITP and dGTP, 0.3 units HotStar Taq (Qiagen), 1 to 5 μl of DNA template, in a total volume of 10 μl. Thermocycler conditions were: 15 min at 95° to activate the enzyme and denature the DNA, 40 cycles of 1 minute denaturation at 94°, 1 minute annealing at 55°, 1.5 minute extension at 72°, followed by one cycle of 10 minute extension at 72°. With these primers, a 4R PCR product is 475 bp. Samples were visualized under UV on 2.0% ethidium bromide agarose gels with a 100 bp ladder. In contrast to previous results using this protocol , varying concentrations of the DNA template did not result in allelic dropout. However, as observed previously at this locus  extra heteroduplex bands formed in several samples. To confirm that these bands were in fact PCR artefacts, two sets of alternative primers were used under identical conditions (F2 5' CGTACTGTGCGGCCTCAACGA 3' and R2 5' GACACAGCGCCTGCGTGATGT 3', 705 bp product for 4R ; and F3 5' CTGCAGCGCTGGGAGGTG 3' and the R1 primer above, 389 bp product for 4R).
DRD2 TaqI A
The DRD2 TaqI A site is a single-nucleotide polymorphism with a major A2, and minor A1 allele. The A1+ genotype (heterozygous or homozygous for A1) has been most strongly associated with substance abuse, particularly alcoholism, albeit with some ambiguity . Although the mechanisms remain poorly understood, the A1 allele is associated with decreases in dopamine D2 binding and glucose metabolic rates in many brain regions [17–19]. The DRD2 TaqI A locus is 9.4 kb downstream from the coding region for the DRD2 gene, is not in any known regulatory region, and has no known mechanism to influence DRD2 expression. The TaqI A polymorphism is also in a nearby kinase gene, the Ankyrin Repeat and Kinase Domain Containing 1 (ANKK1) gene, where it causes a Glutamate→Lysine substitution [88, 89]. The results of the amino acid substitution are not known, but could impact interactions of ANKK1 proteins with other proteins including the dopamine D2 receptor . No other polymorphism has been revealed to be in linkage disequilibrium with TaqI A that could clearly account for its functional associations [88, 89].
DRD2 TaqI A was typed with a PCR/RFLP method [based on [25, 90]]. The PCR reaction contained 0.5 μM forward (5' CACGGCTGGCCAAGTTGTCTA 3'), 0.5 μM reverse primers (5' CACCTTCCTGAGTGTCATCAA3'), 1.25 mM dNTP, 2.5 mM MgCl2, 0.5 units AmpliTaq Gold (ABI), 1× Buffer (ABI), 2 μl DNA template in a total volume of 20 μl. Cycle conditions were: 8 min denaturation at 95°C, 40 cycles of 30 s denaturation at 94°, 30 s annealing at 55°C, 1.5 min extension at 72°C and one final extension of 7 minutes at 72°. The PCR product was digested with TaqI enzyme (New England Biolabs) for at least two hours at 65°C and visualized under UV on a 1% ethidium bromide agarose gel. The 300 bp PCR product is not cut by the restriction enzyme in A1 homozygotes, whereas the A2 allele yields 125 and 175 bp fragments. PCR products for a sample of A1 homozygotes were re-digested to assure proper genotyping.
Androgen Receptor (AR) CAG tri-nucleotide repeat
The AR CAG microsatellite was typed with a PCR mix containing 1.25 μM forward primer (TCCAGAATCTGTTCCAGAGCGTGC) and 1.25 μM reverse primer (GCTGTGAAGGTTGCTGTTCCTCAT), 2.5 mM dNTP, 2.5 mM MgCl2, 0.625 units AmpliTaq Gold (ABI), 1× Buffer (ABI), 3 μl DNA template in a total volume of 25 μl. The reverse AR primer was fluorescently labelled with GeneScan VIC (ABI). Cycle conditions were: 8 min denaturation at 95°C, 40 cycles of 30 s denaturation at 95°, 30 s annealing at 55°, 1 min extension at 72° and one final extension of 7 minutes at 72°. PCR products were analyzed on an ABI 3100 genetic analyzer using GeneMapper 3.7 (ABI). Four random samples were sequenced for length confirmation. The number of trinucleotide repeats was calculated by subtracting 214 bp from the product then dividing by three. The number of repeats ranged from 15–34. A median split at 20 (<= 20 vs. >20) was used for analyses as in .
Saliva samples were collected using standard methods  including stimulation of saliva with Original flavoured Carefree gum. Morning samples were collected within 15 minutes of 09:00 hours, while afternoon saliva samples were collected within 15 minutes of 16:00 hours. Sodium azide was added as a preservative and samples were transported to the Laboratory of Reproductive Ecology at Harvard University where they were assayed using previously described RIA techniques . The interassay coefficient of variation was 15%. Four morning T values and two afternoon T values were more than three SDs from their respective means, and were eliminated from the analyses. Analyses here only use afternoon T values to be consistent with past studies, however results were essentially unchanged when morning T values were included in the models instead (not shown).
All anthropometric variables were examined for distribution normality. HW equilibriums were tested with the HWE program . All other statistical analyses were conducted with SPSS 11. DRD2 HW equilibrium was tested with Fisher's exact test and DRD4 was tested with the Markov Chain algorithm . Two-tailed p values less than or equal to 0.05 were considered significant and values less than or equal to 0.10 were considered near significant.
Based on previous association studies, for the DRD2 TaqI A, individuals with at least one A1 allele were designated as A1+ and those who were homozygous for the A2 allele were designated A1-. Similarly, DRD4 VNTR genotypes were separated into 7R allele present (7+) and 7R absent (7-) groups. Since we recognize that other methods of parsing genotype groups and analyzing the data may be legitimate and further our understanding, we have included, as Additional file 1 and 2, the complete dataset on which this manuscript is based. The analyses used 2 (Settled/Nomadic) × 2 (A1+/A1-) × 2 (7+/7-) General Linear Models (using GLM function in SPSS; including all primary and 2-way effects).
When past results indicated the outcome variable of interest was related to other predictor variables, another model was built which also included the appropriate additional variables. These other variables consisted of testosterone level (afternoon measurement), the androgen receptor (AR) genetic polymorphism, and age group.
Percent Body Fat
Arm Muscle Plus Bone Area
Androgen Receptor genetic polymorphism-CAG trinucleotide repeat
Body Mass Index (weight in kg/m2)
Dopamine Receptor D2
Dopamine Receptor D4
Fat Free Mass
Insulin like Growth Factor I
- Pm T:
Testosterone levels taken in the afternoon
whether the subject is from a nomadic or sedentary community
Spitz MR, Detry MA, Pillow P, Hu YH, Amos CI, Hong WK, Wu XF: Variant alleles of the D2 dopamine receptor gene and obesity. Nutr Res. 2000, 20 (3): 371-380. 10.1016/S0271-5317(00)00130-5.
Comings DE, Gade R, MacMurray JP, Muhleman D, Peters WR: Genetic variants of the human obesity (OB) gene: Association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D-2 receptor (DRD2) gene. Molecular Psychiatry. 1996, 1 (4): 325-335.
Morton LM, Wang SS, Bergen AW, Chatterjee N, Kvale P, Welch R, Yeager M, Hayes RB, Chanock SJ, Caporaso NE: DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenetics and Genomics. 2006, 16 (12): 901-910. 10.1097/01.fpc.0000230417.20468.d0.
Thomas GN, Critchley J, Tomlinson B, Cockram CS, Chan JCN: Relationships between the TaqI polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol. 2001, 55 (5): 605-611. 10.1046/j.1365-2265.2001.01404.x.
Fang YJ, Thomas GN, Xu ZL, Fang JQ, Critchley AJH, Tomlinson B: An affected pedigree member analysis of linkage between the dopamine D2 receptor gene TaqI polymorphism and obesity and hypertension. International Journal of Cardiology. 2005, 102 (1): 111-116. 10.1016/j.ijcard.2004.05.010.
Jenkinson CP, Hanson R, Cray K, Wiedrich C, Knowler WC, Bogardus C, Baier L: Association of dopamine D2 receptor polymorphisms Ser311Cys and TaqIA with obesity or type 2 diabetes mellitus in Pima Indians. Int J Obes. 2000, 24 (10): 1233-1238. 10.1038/sj.ijo.0801381.
Southon A, Walder K, Sanigorski AM, Zimmet P, Nicholson GC, Kotowicz MA, Collier G: The Taq IA and Ser311Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabetes Nutr Metab. 2003, 16 (1): 72-76.
Chen TJH: Reviewing the role of putative candidate genes in "Neurobesigenics," a clinical subtype of Reward Deficiency Syndrome (RDS). Gene Therapy and Molecular Biology. 2007, 11A: 61-74.
Guo GA, North K, Choi S: DRD4 gene variant associated with body mass: The National Longitudinal Study of Adolescent Health. Human Mutation. 2006, 27 (3): 236-241. 10.1002/humu.20282.
Levitan RD, Masellis M, Lam RW, Muglia P, Basile VS, Jain U, Kaplan AS, Tharmalingam S, Kennedy SH, Kennedy JL: Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology. 2004, 29 (1): 179-186. 10.1038/sj.npp.1300314.
Guo G, North KE, Gorden-Larsen P, Bulik CM, Choi S: Body mass, DRD4, physical activity, sedentary behavior, and family socioeconomic status: The add health study. Obesity. 2007, 15 (5): 1199-1206.
Chen CS, Burton M, Greenberger E, Dmitrieva J: Population migration and the variation of dopamine D4 receptor (DRD4) allele frequencies around the globe. Evolution and Human Behavior. 1999, 20 (5): 309-324. 10.1016/S1090-5138(99)00015-X.
Irons W: Adaptively relevant environments versus the environment of evolutionary adaptedness. Evolutionary Anthropology. 1998, 6 (6): 194-204. 10.1002/(SICI)1520-6505(1998)6:6<194::AID-EVAN2>3.0.CO;2-B.
Campbell B, O'Rourke MT, Lipson SF: Salivary testosterone and body composition among Ariaal males. American Journal of Human Biology. 2003, 15 (5): 697-708. 10.1002/ajhb.10203.
Fratkin E: Ariaal Pastoralists of Kenya: Surviving Drought and Development in Africa's Arid Lands. 1998, Needham Heights, MA: Allyn and Bacon
Smith K: Sedentarization and Market Integration: New Opportunities for Rendille and Ariaal Women of Northern Kenya. Human Organization. 1998, 57 (4): 459-468.
Blum K, Braverman E, Holder J, Lubar J, Vincent M, Miller D, Lubar J, Chen T, Comings D: Reward Deficiency Syndrome: A Biogenetic Model for the Diagnosis and Treatment of Impulsive, Addictive and Compulsive Behaviors. Journal of Psychoactive Drugs. 2000, Supplement to 32
Noble EP: D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. American Journal of Medical Genetics Part B-Neuropsychiatric Genetics. 2003, 116B (1): 103-125. 10.1002/ajmg.b.10005.
Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry E: D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics. 1997, 7 (479–484):
Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Vantol HHM: Modulation of Intracellular Cyclic-Amp Levels by Different Human Dopamine D4 Receptor Variants. Journal of Neurochemistry. 1995, 65 (3): 1157-1165.
Czermak C, Lehofer M, Liebmann PM, Traynor J: [S-35]GTP gamma S binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine. European Journal of Pharmacology. 2006, 531 (1–3): 20-24. 10.1016/j.ejphar.2005.11.063.
Schoots O, Van Tol HHM: The human dopamine D4 receptor repeat sequences modulate expression. Pharmacogenomics Journal. 2003, 3 (6): 343-348. 10.1038/sj.tpj.6500208.
Van Tol HHM, Wu CM, Guan H-C, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V: Multiple dopamine D4 receptor variants in the human population. Nature. 1992, 358: 149-152. 10.1038/358149a0.
Van Craenenbroeck K, Clark SD, Cox MJ, Oak JN, Liu F, Van Tol HHM: Folding efficiency is rate-limiting in dopamine D4 receptor biogenesis. Journal of Biological Chemistry. 2005, 280 (19): 19350-19357. 10.1074/jbc.M414043200.
Eisenberg DTA, MacKillop J, Modi M, Beauchemin J, Dang D, Lisman SA, Lum JK, Wilson DS: Examining Impulsivity as an Endophenotype Using a Behavioral Approach: A DRD2 TaqI A and DRD4 48-bp VNTR Association Study. Behavioral and Brain Functions. 2007, 3 (2):
Beaver KM, Wright JP, DeLisi M, Walsh A, Vaughn MG, Boisvert D, Vaske J: A gene × gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males. Behav Brain Funct. 2007, 3: 30-10.1186/1744-9081-3-30.
Hinney A, J S, A Z, al e: No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight, and obesity. Am J Med Genet. 1999, 88: 594-597. 10.1002/(SICI)1096-8628(19991215)88:6<594::AID-AJMG2>3.0.CO;2-F.
Levitan RD, Masellis M, Basile VS, Lam RW, Kaplan AS, Davis C, Muglia P, Mackenzie B, Tharmalingam S, Kennedy SH, et al: The dopamine-4 receptor gene associated with binge eating and weight gain in women with seasonal affective disorder: An evolutionary perspective. Biological Psychiatry. 2004, 56 (9): 665-669. 10.1016/j.biopsych.2004.08.013.
Eisenberg DTA, Campbell B, MacKillop J, Modi M, Dang D, Lum JK, Wilson DS: Polymorphisms in the Dopamine D2 and D4 Receptor Genes and Reproductive, Sexual and Life History Behaviors. Evolutionary Psychology. 2007, 5 (4): 696-715.
Wang E, Ding YC, Flodman P, Kidd JR, Kidd KK, Grady DL, Ryder OA, Spence MA, Swanson JM, Moyzis RK: The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus. Am J Hum Genet. 2004, 74 (5): 931-944. 10.1086/420854.
Chen TJH, Blum K, Kaats G, Braverman ER, Eisenberg A, Sherman M, Davis K, Comings DE, Wood R, Pullin D, et al: Chromium Picolinate (CrP) a putative anti-obesity nutrient induces changes in body composition as a function of the Taq1 dopamine D2 receptor polymorphisms in a randomized double-blind placebo controlled study. Gene Therapy and Molecular Biology. 2007, 11B: 161-170.
Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS: Brain dopamine and obesity. Lancet. 2001, 357 (9253): 354-357. 10.1016/S0140-6736(00)03643-6.
Epstein LH, Wright SM, Paluch RA, Leddy JJ, Hawk LW, Jaroni JL, Saad FG, Crystal-Mansour S, Shields PG, Lerman C: Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. American Journal of Clinical Nutrition. 2004, 80 (1): 82-88.
Epstein LH, Temple JL, Neaderhiser BJ, Salis RJ, Erbe RW, Leddy JJ: Food reinforcement, the dopamine D-2 receptor genotype, and energy intake in obese and nonobese humans. Behav Neurosci. 2007, 121 (5): 877-886. 10.1037/0735-7044.121.5.877.
Arinami T, Iijima Y, Yamakawa-Kobayashi K, Ishiguro H, Ohtsuki T, Yanagi H, Shimakura Y, Ishikawa H, Hamaguchi H: Supportive evidence for contribution of the dopamine D2 receptor gene to heritability of stature: linkage and association studies. Ann Hum Genet. 1999, 63: 147-151. 10.1046/j.1469-1809.1999.6320147.x.
Comings DE, Flanagan SD, Dietz G, Muhleman D, Knell E, Gysin R: The Dopamine-D(2) Receptor (Drd2) as a Major Gene in Obesity and Height. Biochemical Medicine and Metabolic Biology. 1993, 50 (2): 176-185. 10.1006/bmmb.1993.1059.
Miyake H, Nagashima K, Onigata K, Nagashima T, Takano Y, Morikawa A: Allelic variations of the D2 dopamine receptor gene in children with idiopathic short stature. Journal of Human Genetics. 1999, 44 (1): 26-29. 10.1007/s100380050101.
Campbell B, Eisenberg DTA: Obesity, Attention Deficit-Hyperactivity Disorder, and the Dopaminergic Reward System. Collegium Antropologicum. 2007, 31 (1): 315-319.
ALFRED-The Allele Frequency Database: Allele Frequency For Polymorphic Site: Exon 3 48 bp_VNTR. Locus Name: Dopamine receptor D4. ALFRED-The Allele Frequency Database. 2008
Strawbridge WJ: New NHLBI clinical guidelines for obesity and overweight: will they promote health?. Am J Public Health. 2000, 90 (3): 340-343.
National Institutes of H, National Heart LaBI, National Institute of Diabetes and Digestive and Kidney D, Initiative NOE: Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. National Heart, Lung, and Blood Institute. 1998
Campbell BC, Gray PB, Ellison PT: Age-related changes in body composition and salivary testosterone among Ariaal Males. Aging: Clinical and Experimental Research. 2006, 18: 470-476.
Campbell BC, Gray PB, Eisenberg DTA, Ellison P, Sorenson M: Androgen Receptor CAG Repeats and Body Composition among Ariaal Men. International Journal of Andrology. 2007
Frisancho AR: New norms of upper limb fat and muscle areas for assessment of nutritional status. American Journal of Clinical Nutrition. 1981, 34: 2540-2545.
Miller MD, Crotty M, Giles LC, Bannerman E, Whitehead C, Cobiac L, Daniels LA, Andrews G: Corrected arm muscle area: An independent predictor of long-term mortality in community-dwelling older adults?. J Am Geriatr Soc. 2002, 50 (7): 1272-1277. 10.1046/j.1532-5415.2002.50316.x.
Nindl BC, Friedl KE, Marchitelli LJ, Shippee RL, Thomas CD, Patton JF: Regional fat placement in physically fit males and changes with weight loss. Med Sci Sports Exerc. 1996, 28 (7): 786-93.
Diaz-Torga G, Feierstein C, Libertun C, Gelman D, Kelly MA, Low MJ, Rubinstein M, Becu-Villalobos D: Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology. 2002, 143 (4): 1270-1279. 10.1210/en.143.4.1270.
Venken K, Moverare-Skrtic S, Kopchick J, al e: Impact of androgens, growth hormone, and IGF-I on bone and muscle in male mice during puberty. J Bone Miner Res. 2007, 22: 72-82. 10.1359/jbmr.060911.
Clemmons DR: The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity. J Clin Invest. 2004, 113 (1): 25-27.
Piers LS, Soares MJ, McCormack LM, O'Dea K: Is there evidence for an age-related reduction in metabolic rate?. Journal of Applied Physiology. 1998, 85 (6): 2196-2204.
Geinoz G, Rapin CH, Rizzoli R, Kraemer R, Buchs B, Slosman D, Michel JP, Bonjour JP: Relationship between bone-mineral density and dietary intakes in the elderly. Osteoporosis Int. 1993, 3 (5): 242-248. 10.1007/BF01623827.
Bachner-Melman R, Gritsenko I, Nemanov L, Zohar AH, Dina C, Ebstein RP: Dopaminergic polymorphisms associated with self-report measures of human altruism: a fresh phenotype for the dopamine D4 receptor. Molecular Psychiatry. 2005, 10 (4): 333-335. 10.1038/sj.mp.4001635.
Roth EA, Ngugi E, Fujita M: Self-deception does not explain high-risk sexual behavior in the face of HIV/AIDS: A test from northern Kenya. Evolution and Human Behavior. 2006, 27 (1): 53-62. 10.1016/j.evolhumbehav.2005.04.004.
Zion IB, Tessler R, Cohen L, Lerer E, Raz Y, Bachner-Melman R, Gritsenko I, Nemanov L, Zohar A, Belmaker R, et al: Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function. Molecular Psychiatry. 2006, 1-5.
Guo G, Tong YY: Age at first sexual intercourse, genes, and social context: Evidence from twins and the dopamine D4 receptor gene. Demography. 2006, 43 (4): 747-769. 10.1353/dem.2006.0029.
Propper C, Willoughby M, Halpern CT, Carbone MA, Cox M: Parenting Quality, DRD4, and the Prediction of Externalizing and Internalizing Behaviors in Early Childhood. Developmental Psychobiology. 2007, 619-632. 10.1002/dev.20249.
Kang JI, Namkoong K, Kim SJ: Association of DRD4 and COMT polymorphisms with anger and forgiveness traits in healthy volunteers. 2008, 430: 252-257.
Langley K, Marshall L, Bree van den M, Thomas H, Owen M, O'Donovan M, Thapar A: Association of the Dopamine D4 Receptor Gene 7-Repeat Allele With Neuropsychological Test Performance of Children With ADHD. American Journal of Psychiatry. 2004, 161 (1): 133-138. 10.1176/appi.ajp.161.1.133.
Auerbach JG, Faroy M, Ebstein R, Kahana M, Levine J: The association of the dopamine D4 receptor gene (DRD4) and the serotonin transporter promoter gene (5-HTTLPR) with temperament in 12-month-old infants. Journal of Child Psychology and Psychiatry and Allied Disciplines. 2001, 42 (6): 777-783. 10.1111/1469-7610.00774.
Williams J, Taylor E: The evolution of hyperactivity, impulsivity and cognitive diviersity. J R Soc Interface. 2006, 3 (8): 399-413. 10.1098/rsif.2005.0102.
Nisbett RE, Cohen D: Culture of honor: the psychology of violence in the south. 1996, Boulder, CO: Westview Press
Harpending H, Cochran G: In our genes. Proceedings of the National Academy of Sciences of the United States of America. 2002, 99 (1): 10-12. 10.1073/pnas.012612799.
deVries MW: Temperament and infant-mortality among the Masai of East Africa. American Journal of Psychiatry. 1984, 141 (10): 1189-1194.
Ebstein RP, Levine J, Geller V, Auerbach J, Gritsenko I, Belmaker RH: Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. Molecular Psychiatry. 1998, 3 (3): 238-246. 10.1038/sj.mp.4000363.
Gervai J, Novak A, Lakatos K, Toth I, Danis I, Ronai Z, Nemoda Z, Sasvari-Szekely M, Bureau JF, Bronfrnan E, et al: Infant genotype may moderate sensitivity to maternal affective communications: Attachment disorganization, quality of care, and the DRD4 polymorphism. Social Neuroscience. 2007, 2 (3–4): 307-319. 10.1080/17470910701391893.
Gammie SC, Edelmann MN, Mandel-Brehm C, D'Anna KL, Auger AP, Stevenson SA: Altered Dopamine Signaling in Naturally Occurring Maternal Neglect. PLoS ONE. 2008, 3 (4): e1974-10.1371/journal.pone.0001974.
Gilbert C: Optimal physical performance in athletes: Key roles of dopamine in a specific neurotransmitter hormonal mechanism. Mechanisms of Ageing and Development. 1995, 84 (2): 83-102. 10.1016/0047-6374(95)01635-X.
Hasegawa H, Meeusen R, Sarre S, Diltoer M, Piacentini MF, Michotte Y: Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats. Journal of Applied Physiology. 2005, 99 (4): 1397-1401. 10.1152/japplphysiol.00435.2005.
Watson P, Hasegawa H, Roelands B, Piacentini MF, Looverie R, Meeusen R: Acute dopamine/noradrenaline reuptake inhibition enhances human exercise performance in warm, but not temperate conditions. J Physiol. 2005, 565 (3): 873-883. 10.1113/jphysiol.2004.079202.
Wilson DS: Adaptive Genetic-Variation and Human Evolutionary Psychology. Ethology and Sociobiology. 1994, 15 (4): 219-235. 10.1016/0162-3095(94)90015-9.
Wang ET, Moyzis RK: Genetic evidence for ongoing balanced selection at human DNA repair genes ERCC8, FANCC, and RAD51C. Mutation Research-Fundamental and Molecular Mechanisms of Mutagenesis. 2007, 616 (1–2): 165-174. 10.1016/j.mrfmmm.2006.11.030.
Gray P, Campbell B: Erectile dysfunction and its correlates among the Ariaal of northern Kenya. International Journal of Impotence Research. 2005, 17 (5): 445-449. 10.1038/sj.ijir.3901359.
Durnin J, Womersley J: Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16–72 years. British Journal of Nutrition. 1974, 32: 77-97. 10.1079/BJN19740060.
Gurney J, Jellife D: Arm anthropometry in nutritional assessment: nomogram for rapid calculation of muscle circumference and cross-sectional muscle and fat areas. American Journal of Clinical Nutrition. 1973, 26: 912-915.
Ding YC, Chi HC, Grady DL, Morishima A, Kidd JR, Kidd KK, Flodman P, Spence MA, Schuck S, Swanson JM, et al: Evidence of positive selection acting at the human dopamine receptor D4 gene locus. Proceedings of the National Academy of Sciences of the United States of America. 2002, 99 (1): 309-314. 10.1073/pnas.012464099.
Asghari V, Schoots O, Vankats S, Ohara K, Jovanovic V, Guan HC, Bunzow JR, Petronis A, Vantol HHM: Dopamine D4 Receptor Repeat – Analysis of Different Native and Mutant Forms of the Human and Rat Genes. Molecular Pharmacology. 1994, 46 (2): 364-373.
Oak JN, Lavine N, Tol HHMV: Dopamine D4 and D2L Receptor Stimulation of the Mitogen-Activated Protein Kinase Pathway Is Dependent on trans-Activation of the Platelet-Derivied Growth Factor Receptor. Molecular Pharmacology. 2001, 60 (1): 92-103.
Jovanovic V, Guan HC, Van Tol HHM: Comparative pharmacological and functional analysis of the human dopamine D-4.2 and D-4.10 receptor variants. Pharmacogenetics. 1999, 9 (5): 561-568. 10.1097/00008571-199910000-00003.
Watts VJ, Vu MN, Wiens BL, Jovanovic V, Tol HHMV, Neve KA: Short- and long-term heterologous sensitization of adenylate cyclase by D4 dopamine receptors. Psychopharmacology. 1999, 141: 84-92. 10.1007/s002130050810.
Cho DI, Beorn S, Van Tol HHM, Caron MG, Kim KM: Characterization of the desensitization properties of five dopamine receptor subtypes and alternatively spliced variants of dopamine D-2 and D-4 receptors. Biochemical and Biophysical Research Communications. 2006, 350 (3): 634-640. 10.1016/j.bbrc.2006.09.090.
Hamarman S, Fossella J, Ulger C, Brimacombe M, Dermody J: Dopamine receptor 4 (DRD4) 7-repeat allele predicts methylphenidate dose response in children with attention deficit hyperactivity disorder: A pharmacogenetic study. Journal of Child and Adolescent Psychopharmacology. 2004, 14 (4): 564-574. 10.1089/cap.2004.14.564.
Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, Zamora-Paja E, Farahi J, Saxena S, London ED, et al: Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry. 2006, 63 (7): 808-816. 10.1001/archpsyc.63.7.808.
Hutchison KE, Wooden A, Swift RM, Smolen A, McGeary J, Adler L, Paris L: Olanzapine reduces craving for alcohol: A DRD4 VNTR polymorphism by pharmacotherapy interaction. Neuropsychopharmacology. 2003, 28 (10): 1882-1888. 10.1038/sj.npp.1300264.
Hutchison KE, Ray L, Sandman E, Rutter MC, Peters A, Davidson D, Swift R: The effect of olanzapine on craving and alcohol consumption. Neuropsychopharmacology. 2006, 31 (6): 1310-1317.
McGough J, McCracken J, Swanson J, Riddle M, Kollins S, Greenhill L, Abikoff H, Davies M, Chuang S, Wigal T, et al: Pharmacogenetics of methylphenidate response in preschoolers with ADHD. Journal of the American Academy of Child and Adolescent Psychiatry. 2006, 45 (11): 1314-1322. 10.1097/01.chi.0000235083.40285.08.
Boór K, Rónai Z, Nemoda Z, Gaszner P, Sasvári-Székely M, Guttman A, Kalász H: Noninvasive Genotyping of Dopamine Receptor D4 (DRD4) Using Nanograms of DNA From Substance-Dependent Patients. Current Medicinal Chemistry. 2002, 9: 793-797. 10.2174/0929867024606821.
Ronai Z: Personal Communication. Edited by: Eisenberg D. 2006
Dubertret C, Gouya L, Hanoun N, Deybach JC, Ades J, Hamon M, Gorwood P: The 3 ' region of the DRD2 gene is involved in genetic susceptibility to schizophrenia. Schizophr Res. 2004, 67 (1): 75-85. 10.1016/S0920-9964(03)00220-2.
Neville MJ, Johnstone EC, Walton RT: Identification and characterization of ANKK1: A novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Human Mutation. 2004, 23 (6): 540-545. 10.1002/humu.20039.
GSFL Genotyping Protocol – DRD2 (Dopamine Receptor D2) Taq1"A". [http://www.chmeds.ac.nz/research/gsfl/drd2taqarflp.pdf]
Ellison PT: Human salivary steroids: methodological considerations and applications in physical anthropology. Yearbook of Physical Anthropology. 1988, 31: 1115-1142. 10.1002/ajpa.1330310507.
Hardy-Weinberg Equilibrium Test. [http://www2.biology.ualberta.ca/jbrzusto/hwenj.html]
Guo SW, Thompson EA: Performing the Exact Test of Hardy-Weinberg Proportion for Multiple Alleles. Biometrics. 1992, 48: 361-372. 10.2307/2532296.
We thank Daniel Lemoille and Jason Radak for help with data collection, Brad Stankiewicz for extracting DNA from hair samples, Peter Ellison and Susan Lipson of the Reproductive Ecology Laboratory at Harvard for testosterone analysis, Henry Harpending and Thomas McDade for valuable comments, and the Ariaal men for their participation. This work was supported by the Wenner-Gren Foundation. DTAE drafted this manuscript in part while funded by the TAPS NSF field-school in Beni, Bolivia where he received valuable commentary from the other participants and in part while funded by an NSF Graduate Research Fellowship.
DTAE co-conceived of the study, carried out genetic laboratory analysis, helped develop genetic laboratory protocols, analyzed the data and wrote the manuscript. BC co-conceived the study, collected samples and phenotype data and assisted in analysis of data and manuscript preparation. PBG collected samples and phenotype data. MDS supervised genetic laboratory analyses, designed primers and helped develop genetic laboratory protocols. All authors read and approved the final manuscript.
Electronic supplementary material
Additional file 1: Dataset. Entire dataset used for analysis in this manuscript and some additional variables (XLS 180 KB)
Additional file 2: Dataset Legend. Description of variables (column headings) given in Additional file 1. This file also contains descriptions of some variables NOT included in Additional file 1. Those interested in those variables not included in file 1 should contact the authors. (XLS 25 KB)
About this article
Cite this article
Eisenberg, D.T., Campbell, B., Gray, P.B. et al. Dopamine receptor genetic polymorphisms and body composition in undernourished pastoralists: An exploration of nutrition indices among nomadic and recently settled Ariaal men of northern Kenya. BMC Evol Biol 8, 173 (2008). https://doi.org/10.1186/1471-2148-8-173
- Androgen Receptor
- DRD2 Gene
- Food Craving
- VNTR Polymorphism
- DRD4 Genotype